Clinical Trial

SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy

Name: SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy — clinical trial record (NCT07096999)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study is being performed to establish the association between absorbed dose to tumor and response and absorbed dose to normal organs and toxicity following Lu177-PSMA radioligand therapy

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-07-24.

Trial Details

NCT Number	NCT07096999
Lead Sponsor	University of Michigan Rogel Cancer Center Collaborators: National Cancer Institute (NCI)
Conditions	Metastatic Castration-Resistant Prostate Carcinoma
Enrollment	60 participants
Start Date	2025-01-23
Primary Completion	2031-01-23 (estimated)
Study Completion	2031-01-23 (estimated)
Updated on ClinicalTrials.gov	2026-07-27